Scientific Research: Publications

April 2023

How clinicians may use tests of hepatic function now and in the future.

Ghaziani TT, Kwo PY. | Translational Research 2021

In this editorial, Ghaziani and Kwo highlight the potential uses of the HepQuant SHUNT test. The applications are many and encompass many aspects of the field of Hepatology. read more →

April 2023

Editorial: Stratifying risk of adverse outcomes in cirrhosis: the HepQuant SHUNT

Maan R, Sonneveld MJ | Alimentary Pharmacology and Therapeutics

August 2022

HepQuant SHUNT is Superior to Child-Pugh in Defining Hepatic Impairment for Pharmacokinetic Studies: Experience with Ampreloxetine (An Encore Presentation)

Kanodia J, Giovinazzo H, Yates W, Bourdet D, Helmke S, Everson GT. | Hepatology 2022; AASLD accepted poster presentation.

One of the key uses of HepQuant in drug development may be to gain better knowledge of the relationship of drug AUC to liver function quantified by HepQuant. The current method of use of Child Pugh class or score is imprecise. In this poster we present relationships of HepQuant SHUNT test parameters to PK of ampreloxetine. DSI and other test parameters were better than CP score in predicting drug PK

Scientific Research: Posters & Presentations

Professional Organizations

  • American Association for the Study of Liver Disease (AASLD)
  • American Gastroenterological Association (AGA)
  • American College of Gastroenterology (ACG)
  • American Society of Transplantation (AST)
  • American Society of Pediatric Gastroenterology and Nutrition (NASPGHAN)
  • European Association for the Study of the Liver (EASL)
  • Asian Pacific Association for the Study of the Liver (APASL)
  • International Liver Transplant Society (ILTS)
  • American Heart Association (AHA)
  • American Cancer Society (ACS)

Patient Support Groups